**Question:** The treatment of choice for a case of congestive failure with hypertension is –

A. Angiotensin-converting enzyme inhibitors
B. Calcium channel blockers
C. Diuretics
D. Beta-blockers

**Core Concept:**

In patients with congestive heart failure (CHF) and coexisting hypertension, the appropriate management aims to reduce afterload (blood pressure), preload (blood volume), and heart rate to improve cardiac output and reduce the workload on the heart. Several drug classes can be employed to achieve these goals, but the correct treatment options should be tailored to the patient's specific condition and comorbidities.

**Why the Correct Answer is Right:**

1. **Angiotensin-converting enzyme inhibitors (Ace inhibitors):** These medications inhibit the renin-angiotensin-aldosterone system (RAAS) cascade, leading to reduced cardiac afterload, decreased aldosterone release, and preserved renal function. Ace inhibitors are generally preferred in patients with CHF and hypertension due to their favorable effects on cardiac and renal function.
2. **Beta-blockers (e.g., carvedilol):** These drugs reduce heart rate, decrease myocardial oxygen demand, and improve cardiac contractility. Beta-blockers are beneficial in CHF management, but their use may be limited in some cases due to potential adverse effects (e.g., worsening of CHF in patients with severe asthma or bradycardia).
3. **Calcium channel blockers (e.g., amlodipine):** These medications reduce peripheral resistance, lowering blood pressure and thereby cardiac afterload. Calcium channel blockers are often chosen when there is a concern for potential beta-blocker-induced hypotension or worsening CHF.
4. **Diuretics (e.g., furosemide):** These medications facilitate the excretion of sodium and water from the body, decreasing preload (blood volume) and helping to relieve congestion in CHF patients. Diuretics are commonly used in combination with other antihypertensive agents to achieve optimal blood pressure control.

**Why Each Wrong Option is Incorrect:**

1. **Diuretics (e.g., prazosin):** Prazosin is a alpha-blocker primarily used to treat hypertension by blocking alpha-1 receptors and reducing systemic vascular resistance. While it can be effective in controlling blood pressure, it is not the ideal choice for CHF management, as it does not address the preload component of hypertension in CHF patients.
2. **Angiotensin II receptor blockers (e.g., losartan):** These medications act on the RAAS system, reducing blood pressure, but are typically chosen for hypertension independently of CHF. Their use in the context of CHF management may worsen cardiac output and worsen the patient's condition.
3. **Beta-blockers (e.g., atenolol):** As mentioned earlier, beta-blockers like atenolol are not recommended for CHF management due to potential worsening of the patient's condition and increased risk of hypotension or bradycardia when used in